TP53 and lung adenocarcinoma: Recent research showed that RPS27A could interact with RPL11, and loss of RPS27A could inhibit cell viability and cell cycle, inducing apoptosis via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells (Wu et al., 2020).